Tumblelog by Soup.io
Newer posts are loading.
You are at the newest post.
Click here to check if anything new just came in.

Cme Outfitters? Two-part Medical Simulation On Psoriasis Featuring Expert Faculty Commentary Now Available Online

Armstrong, MD, MPH, and Alan Menter, MD welcome participation in the two-part medical simulation Not Just Skin Deep: Psoriasis, Parts I and II Bethesda, Maryland (PRWEB) April 09, 2015 CME Outfitters (CMEO), a leading accredited provider in continuing medical education, announces its newest CMEO Medical Simulations, Not Just Skin Deep: Psoriasis Parts I and II . Faculty experts April W. Armstrong, MD, MPH, and Alan Menter, MD guide you through the simulations to improve your knowledge base and clinical management skills in patients with psoriasis, and improve your knowledge of psoriasis comorbidities and clinical strategies to improve long-term patient outcomes. Dermatologists, physicians, and other health care professionals, including pharmacists, nurses, physician assistants, and nurse practitioners who have an interest in psoriasis are encouraged to participate. Patients with moderate-to-severe psoriasis are at risk for a variety of comorbidities. Dermatologists are in a unique position to screen for these comorbidities and counsel patients to be aware of early symptoms and risk factors.
For the original version including any supplementary images or video, visit http://www.prweb.com/releases/2015/04/prweb12637639.htm

Research and Markets: Global Psoriasis Pipeline Highlights Report 2014-2017 - Yahoo Finance

Thomas Dirschka (dermatologist, Germany), Cristiana Oliveira (Actress and rosacea sufferer, Brazil) and Dr. Christoph Martschin (dermatologist, Sweden). The Coalition has agreed a set of core principles: Raise awareness of the symptoms associated with rosacea (>50% are unaware that their symptoms are caused by rosacea) De-stigmatize rosacea and help sufferers understand its a common medical condition Deliver high quality information and resources to people affected by the condition and who may have previously struggled to get the help they need Encourage sufferers to have the confidence to speak with their doctor A number of the Coalition members will be participating in the first Global Rosacea Tweetathon (#ChatRosacea) on Monday, April 27th. Global Rosacea Tweetathon The Global Rosacea Tweetathon is a Twitter based conversation between experts in rosacea, sufferers and anyone wanting to better understand the condition.
For the original version including any supplementary images or video, visit http://finance.yahoo.com/news/leading-rosacea-experts-join-forces-120000775.html

Biofrontera AG: Biofrontera significantly increases its turnover in Germany in 2014 - Yahoo Finance

The good news is that a lot of the newer treatments that are remarkably effective for psoriasis also work well for psoriatic as well as rheumatoid arthritis. Recent studies have also linked psoriasis to heart disease, stroke, and poor blood pressure management. While doctors arent sure of the exact relationship between these conditions, they suspect that inflammation plays a role here, too. People with psoriasisalong with eczema and other skin conditions like scleroderma, which causes hardening of the skinare also more likely than people without psoriasis to be smokers, heavy drinkers, or to suffer from depression or anxiety. These disorders are potentially the effects of having a chronic, debilitating, and very visible disorder, and they may actually trigger disease or worsen prognosis, Silverberg said. Stasis dermatitis This is a darkening or discoloration of the skin on your legs and ankles caused by varicose veins or another circulatory problem that leads to swelling that blocks blood flow to the skin.
For the original version including any supplementary images or video, visit http://www.foxnews.com/health/2015/04/09/4-skin-conditions-that-can-signal-other-health-problems/

Psoria-Shield, Inc. Reports Successful Exhibition at the American Academy of Dermatology's 73rd Annual Meeting - Yahoo Finance

Short-term Launch Highlights: Find out which Psoriasis pipeline products will be launched in the US and Ex-US till 2017. Key Topics Covered: 1. Psoriasis Pipeline by Stages 2. Psoriasis Pipeline by Drug Class 3. Psoriasis Pipeline by Company 4. Psoriasis Phase 3 Clinical Trial Insights 5. Psoriasis Phase 2 Clinical Trial Insights 6.
For the original version including any supplementary images or video, visit http://finance.yahoo.com/news/research-markets-global-psoriasis-pipeline-104300215.html

4 skin conditions that can signal other health problems | Fox News

This persistence was found despite human skin shedding millions of skin cells each day. "A lot can be known in terms of an individual and their lifestyle," he adds. Location, location, location Different types of bacteria are known to predominate certain parts of the body, due to factors such as moisture, which can aid their growth and development. For this reason, when mapped, the feet were the largest home for bacteria such as staphylococcus, whereas bacteria associated with conditions such as acne were predictably found in higher numbers on the face and upper back. "But we don't know what they're doing there," says Dorrestein for whom this study is just a snapshot.
For the original version including any supplementary images or video, visit http://www.wgal.com/health/maps-reveal-the-bacteria-lurking-on-skin/32272244

Leading Rosacea Experts Join Forces for Inaugural Global Rosacea Awareness Month to Help Drive Awareness and Extend Support for the 40 Million People Affected by Rosacea Worldwide - Yahoo Finance

Outlook 2015: moving forward with the approval process, increasing turnover Biofrontera will continue to pursue its two most important objectives: the approval of Ameluz to treat actinic keratosis in the psoriasis skin disorder USA and the extension of the indications to include basal cell carcinoma in Europe. We are currently compiling the dossier with all the study results for the FDA and want to submit this during the second quarter of 2015. About one year is then expected to be required to be granted approval.
For the original version including any supplementary images or video, visit http://finance.yahoo.com/news/biofrontera-ag-biofrontera-significantly-increases-060202614.html

Maps reveal the bacteria lurking on skin | Health - WGAL Home

Psoria-Light's unique features enable service providers with extended benefits in patient outcomes, patient records, treatment comfort, and acquisition costs when compared to conventional Excimer lasers. According to Chris Waugh, Founder and Director of The Medical Alliance, Psoria-Shield, Inc. anticipates having all primary US markets covered by August 2015. Waugh noted that "the International markets have long demonstrated interest in non-invasive phototherapy.
For the original version including any supplementary images or video, visit http://finance.yahoo.com/news/psoria-shield-inc-reports-successful-134000470.html

Don't be the product, buy the product!